Stereotaxis, Inc. STXS
1.01 USD +0.06 (+6.75%)
Regular-session close
1.00 -0.01 -0.99%
After hours · Nov 19, 4:02 PM ET
0.95 Day range 1.07
0.80 52-week range 2.86
- YTD
- -56.09%
- 1 year
- -54.91%
News
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Bio Green Med Solution (NASDAQ:BGMS) shares moved upwards by 7.9% to $0.65 during Thursday's after-market session. The company's market cap stands at $3.8 million. ZeroStack (NASDAQ:ZSTK)…benzinga.com TD Cowen Maintains Buy on Stereotaxis, Lowers Price Target to $2 TD Cowen analyst Joshua Jennings maintains Stereotaxis (AMEX:STXS) with a Buy and lowers the price target from $3 to $2.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 13.2% to $1.29 during Wednesday's pre-market session. The company's market cap stands at $5.4 million. The company's, Q2 earnings came…
benzinga.com Why Fossil Group Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket Fossil surged 26% after beating Q3 estimates and raising FY26 sales guidance; SHF and OMH led gainers, while STAK and LWLG fell.
benzinga.com Stereotaxis Q3 2026 Earnings Call Transcript Stereotaxis (AMEX:STXS) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 13.9% to $2.2 during Tuesday's after-market session. The company's market cap stands at $73.3 million. Longeveron (NASDAQ:LGVN) stock…benzinga.com Stereotaxis Announces Up To $24M Convertible Note Financing; $12M Initial Funding Plus $12M Milestone-Based Availability Stereotaxis, Inc. (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has entered into definitive agreements with…
benzinga.com Stereotaxis Q3 EPS $(0.07) Misses $(0.05) Estimate, Sales $8.925M Miss $9.600M Estimate Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is unchanged from the same period last year. The…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Curis (NASDAQ:CRIS) stock moved upwards by 83.5% to $1.31 during Wednesday's pre-market session. The company's market cap stands at $1.7 million. SCWorx (NASDAQ:WORX) stock increased by…benzinga.com Stereotaxis Announces 100% Clinical Success Rate For Its Robocath's Robotic System At Transcatheter Cardiovascular Therapeutics Conference; Technical Success Reported At 95% Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the findings from the first-in-human clinical results for…
benzinga.com Canon Medical Systems, Stereotaxis Announce Technology Compatibility And Commercial Collaboration To Pair Alphenix Interventional Imaging Platform With Genesisx Robotic Magnetic Navigation System Collaboration brings together Canon’s Alphenix interventional fluoroscopy system and Stereotaxis’ GenesisX robotic technologyTechnologies will be presented at TCT 2026 in the Canon boothTUSTIN,…
benzinga.com Stereotaxis Says Pauls Stradiņš Clinical University Hospital In Latvia, Establishes Robotic Center For Treatment Of Cardiac Arrhythmias In Latvia And Treats Initial Patients With Genesis Robotic Magnetic Navigation System Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the treatment of cardiac arrhythmia in LatviaFirst…
